Types of AdMs
| . | AdMs (n = 35) . | SyM (n = 16) . | SPM in TI patients with NDMM (n = 19) . | SPM in patients treated with Len (n = 12) . |
|---|---|---|---|---|
| Hematologic malignancies, n (%) | 9 (26) | 8 (50) | 1 (5) | 1 (8) |
| Myelodysplastic syndromes | 3 | 3 | ||
| Myeloproliferative neoplasms | 3 | 3 | ||
| Lymphoid blood diseases | 2 | 2 | ||
| Acute lymphoblastic leukemia | 1 | 0 | 1 | 1 |
| Solid malignancies, n (%) | 26 (74) | 8 (50) | 18 (95) | 11 (92) |
| Colorectal | 7 | 2 | 5 | 4 |
| Prostate | 4 | 2 | 2 | 1 |
| Breast | 2 | 1 | 1 | 1 |
| Lung | 3 | 2 | 1 | |
| Bladder | 2 | 1 | 1 | |
| Kidney | 2 | 2 | 1 | |
| Melanoma | 2 | 2 | 1 | |
| Head and neck | 1 | 1 | 1 | |
| Liver and bile duct | 2 | 2 | 1 | |
| Pseudomyxoma peritonei | 1 | 1 | 1 |
| . | AdMs (n = 35) . | SyM (n = 16) . | SPM in TI patients with NDMM (n = 19) . | SPM in patients treated with Len (n = 12) . |
|---|---|---|---|---|
| Hematologic malignancies, n (%) | 9 (26) | 8 (50) | 1 (5) | 1 (8) |
| Myelodysplastic syndromes | 3 | 3 | ||
| Myeloproliferative neoplasms | 3 | 3 | ||
| Lymphoid blood diseases | 2 | 2 | ||
| Acute lymphoblastic leukemia | 1 | 0 | 1 | 1 |
| Solid malignancies, n (%) | 26 (74) | 8 (50) | 18 (95) | 11 (92) |
| Colorectal | 7 | 2 | 5 | 4 |
| Prostate | 4 | 2 | 2 | 1 |
| Breast | 2 | 1 | 1 | 1 |
| Lung | 3 | 2 | 1 | |
| Bladder | 2 | 1 | 1 | |
| Kidney | 2 | 2 | 1 | |
| Melanoma | 2 | 2 | 1 | |
| Head and neck | 1 | 1 | 1 | |
| Liver and bile duct | 2 | 2 | 1 | |
| Pseudomyxoma peritonei | 1 | 1 | 1 |